Telecommunication | Research Reports, News, Events, Research on Demand

Research Reports Titles

  • United States Zoledronic Acid Market Report 2016

    Notes: Sales, means the sales volume of Zoledronic Acid Revenue, means the sales value of Zoledronic Acid This report studies sales (consumption) of Zoledronic Acid in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering Natco Pharma Ltd. Taj Pharmaceuticals Ltd Emcure Pharmaceuticals Mustafa Nevzat Teva Pharmaceutical Industries Ltd CIPLA Ltd MYLAN ScinoPharm Taiwan, LTD. Gador S.A. Tecoland Corp. Aosaikang Pharm Nanjing Pharm Lianyungang Runzhong Pharm Hangzhou Longshine Bio-Tech Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Zoledronic Acid in each application, can be divided into Zoledronic Acid injection Others Application 3

    • Release Date: September 20, 2016
    • Price: USD 3800
    • Format: Pdf

  • United States Medicine In Prostate Cancer Market Report 2016

    Notes: Sales, means the sales volume of Medicine In Prostate Cancer Revenue, means the sales value of Medicine In Prostate Cancer This report studies sales (consumption) of Medicine In Prostate Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Bristol-Myers Squibb AstraZeneca Eli Lilly Roche GSK Novartis Pfizer Sanofi Bayer Celgene Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Medicine In Prostate Cancer in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: September 20, 2016
    • Price: USD 3800
    • Format: Pdf

  • United States Nonalcoholic Fatty Liver Disease Market Report 2016

    Notes: Sales, means the sales volume of Nonalcoholic Fatty Liver Disease Revenue, means the sales value of Nonalcoholic Fatty Liver Disease This report studies sales (consumption) of Nonalcoholic Fatty Liver Disease in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Conatus Pharmaceuticals Daewoong Pharmaceutical Galmed International Kyorin Pharmaceutical Metabolic Solutions Development Novartis AG Phenex Pharmaceuticals Raptor Pharmaceuticals TCM Biotech International Tobira Therapeutics Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Nonalcoholic Fatty Liver Disease in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: September 20, 2016
    • Price: USD 3800
    • Format: Pdf

  • Europe Acute Myeloid Leukemia Therapeutics Market Report 2016

    Notes: Sales, means the sales volume of Acute Myeloid Leukemia Therapeutics Revenue, means the sales value of Acute Myeloid Leukemia Therapeutics This report studies sales (consumption) of Acute Myeloid Leukemia Therapeutics in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Bristol Myers Squibb Celgene Johnson & Johnson Pfizer Eisai F. Hoffmann-La Roche Immune Pharmaceuticals Innate Pharma Kanisa Pharmaceuticals Meda Merck Sharp & Dohme Midas Pharmaceuticals Neovii Biotech Nippon Shinyaku Novo Nordisk Sanofi Sunesis Pharmaceuticals Teva Pharmaceutical Tolero Pharmaceuticals Cyclacel Pharmaceuticals Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Acute Myeloid Leukemia Therapeutics in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia Italy Spain Benelux Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on sales, market share and growth rate of Acute Myeloid Leukemia Therapeutics in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: September 20, 2016
    • Price: USD 3900
    • Format: Pdf

  • Europe Cancer Biomarkers Market Report 2016

    Notes: Sales, means the sales volume of Cancer Biomarkers Revenue, means the sales value of Cancer Biomarkers This report studies sales (consumption) of Cancer Biomarkers in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Abbott Laboratories Affymetrix Illumina Qiagen? Quest Diagnostics Roche Diagnostics Immunomedics Morphotek Myriad Genetics Nodality Northwest Biotherapeutics Ocimum Biosolutions Oncothyreon OriGene Polymedco Radient Pharmaceuticals Randox Laboratories Siemens Healthcare US Biomarkers Vermillion Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Cancer Biomarkers in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia Italy Spain Benelux Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on sales, market share and growth rate of Cancer Biomarkers in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: September 20, 2016
    • Price: USD 3900
    • Format: Pdf

  • Europe Gynecological Cancers Drug Market Report 2016

    Notes: Sales, means the sales volume of Gynecological Cancers Drug Revenue, means the sales value of Gynecological Cancers Drug This report studies sales (consumption) of Gynecological Cancers Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Covidien llc (Medtronic) Johnson & Johnson MEDICAL Bolton Surgical Platts & Nisbett Frankenman International Changzhou Waston Jiangsu Qianjing Medical Changzhou Anker Medical Changzhou Tongchuang Medical Jiangsu Reable Medical Changzhou Resource Medical Jiangsu Kangjin Medical ... Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Gynecological Cancers Drug in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia Italy Spain Benelux Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on sales, market share and growth rate of Gynecological Cancers Drug in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: September 20, 2016
    • Price: USD 3900
    • Format: Pdf

  • Europe Kidney Cancer Drug Market Report 2016

    Notes: Sales, means the sales volume of Kidney Cancer Drug Revenue, means the sales value of Kidney Cancer Drug This report studies sales (consumption) of Kidney Cancer Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Bayer F. Hoffmann-La Roche GlaxoSmithKline Novartis Pfizer Abbott Laboratories Active Biotech Amgen Argos Therapeutics ArQule AVEO Pharmaceuticals Bionomics Bristol-Myers Squibb Cerulean Pharma Exelixis Genentech immatics biotechnologies Immunicum Ono Pharmaceutical Onyx Therapeutics Oxford BioMedica Prometheus Laboratories Seattle Genetics Taiwan Liposome TRACON Pharmaceuticals Wilex Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Kidney Cancer Drug in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia Italy Spain Benelux Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on sales, market share and growth rate of Kidney Cancer Drug in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: September 20, 2016
    • Price: USD 3900
    • Format: Pdf

  • Europe Prostate Cancer Drugs Market Report 2016

    Notes: Sales, means the sales volume of Prostate Cancer Drugs Revenue, means the sales value of Prostate Cancer Drugs This report studies sales (consumption) of Prostate Cancer Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Abbvie Astra Zeneca Janssen Pharmaceuticals Sanofi Amgen Astellas Pharma Bayer BMS Dendreon Endo Pharmaceuticals Ferring Pharmaceutical Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Prostate Cancer Drugs in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia Italy Spain Benelux Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on sales, market share and growth rate of Prostate Cancer Drugs in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: September 20, 2016
    • Price: USD 3900
    • Format: Pdf

  • Global Acute Lymphocytic Leukemia Drug Sales Market Report 2016

    Notes: Sales, means the sales volume of Acute Lymphocytic Leukemia Drug Revenue, means the sales value of Acute Lymphocytic Leukemia Drug This report studies sales (consumption) of Acute Lymphocytic Leukemia Drug in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Amgen Bristol-Myers Squibb Novartis Ariad Arno Therapeutics Baxter Boehringer Ingelheim ERYTECH Pharma Fate Therapeutics Jazz Pharmaceuticals Orphan Europe Otsuka Ono Pharmaceuticals Onconova Therapeutics Pfizer Regeneron Pharmaceuticals Sanofi Sigma-Tau Pharmaceuticals Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Acute Lymphocytic Leukemia Drug in these regions, from 2011 to 2021 (forecast), like USA China Europe Japan India Southeast Asia Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Oral Parenteral Type III Split by applications, this report focuses on sales, market share and growth rate of Acute Lymphocytic Leukemia Drug in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: September 20, 2016
    • Price: USD 4000
    • Format: Pdf

  • Global Chemotherapy Induced Nausea Sales Market Report 2016

    Notes: Sales, means the sales volume of Chemotherapy Induced Nausea Revenue, means the sales value of Chemotherapy Induced Nausea This report studies sales (consumption) of Chemotherapy Induced Nausea in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering GlaxoSmithKline Helsinn? Heron Therapeutics? Merck & Co Tesaro Acacia Pharma Aphios Barr Laboratories Baxter Healthcare Eisai Especificos Stendhal F.Hoffmann La Roche Mundipharma Mylan Pharmaceuticals OPKO Health Orchid Healthcare Otsuka Pharmaceutical ProStrakan Sandoz (Novartis) Solvay Pharmaceuticals Specialised Therapeutics Australia Sun Pharma Taiho Pharmaceutical? Teva Pharmaceuticals? Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Chemotherapy Induced Nausea in these regions, from 2011 to 2021 (forecast), like USA China Europe Japan India Southeast Asia Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Chemotherapy Induced Nausea in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: September 20, 2016
    • Price: USD 4000
    • Format: Pdf


Create Account



Log In Your Account